90Y微球数量在肝动脉放射性栓塞术（TARE）中的剂量学重要性。 - Suppr

Suppr

超能文献

The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).

作者信息

Spreafico Carlo, Maccauro Marco, Mazzaferro Vincenzo, Chiesa Carlo

机构信息

Radiology 2, Foundation IRCCS National Tumor Institute, Via G. Venezian 1, 20133, Milan, Italy,

出版信息

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):634-8. doi: 10.1007/s00259-013-2674-6.

DOI:10.1007/s00259-013-2674-6

PMID:24477451

Abstract

摘要

相似文献

The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).90Y微球数量在肝动脉放射性栓塞术（TARE）中的剂量学重要性。

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):634-8. doi: 10.1007/s00259-013-2674-6.

Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.钇-90 放射性栓塞治疗不可切除的混合型肝细胞-胆管细胞癌的结果。

J Vasc Interv Radiol. 2020 May;31(5):701-709. doi: 10.1016/j.jvir.2019.09.028. Epub 2020 Feb 29.

Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.延长货架寿命（90）Y 玻璃微球的持续安全性和疗效：134 例患者队列的长期随访。

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):486-93. doi: 10.1007/s00259-013-2575-8. Epub 2013 Oct 10.

Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.肝细胞癌经钇90微球放射性栓塞后非肿瘤性肝脏的组织学变化：2例报告

Semin Liver Dis. 2014 Nov;34(4):465-8. doi: 10.1055/s-0034-1394145. Epub 2014 Nov 4.

Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models.经动脉放射栓塞治疗肝细胞癌和肝转移瘤：临床方面和剂量学模型。

Semin Radiat Oncol. 2020 Jan;30(1):68-76. doi: 10.1016/j.semradonc.2019.08.005.

Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.采用大于 400 灰度的玻璃微球行节段性钇-90 放射性栓塞治疗肝内胆管细胞癌：初步经验。

J Vasc Interv Radiol. 2023 Nov;34(11):1970-1976.e1. doi: 10.1016/j.jvir.2023.07.028. Epub 2023 Aug 1.

Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.经动脉钇-90玻璃微球放射性栓塞治疗肝内胆管癌：单机构回顾性研究结果

J Vasc Interv Radiol. 2018 Aug;29(8):1101-1108. doi: 10.1016/j.jvir.2018.04.001. Epub 2018 Jul 2.

Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.钇[90Y]微球放射性栓塞治疗不可切除的肝内胆管细胞癌。

Future Oncol. 2017 Jun;13(15):1301-1310. doi: 10.2217/fon-2017-0022. Epub 2017 Mar 27.

Segmental Pneumonitis after Radioembolization.

J Vasc Interv Radiol. 2018 Sep;29(9):1305-1306. doi: 10.1016/j.jvir.2018.04.010.

Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.钇[90Y]经动脉放射性栓塞治疗化疗耐药性肝内胆管癌：一项前瞻性观察研究。

J Vasc Interv Radiol. 2019 Aug;30(8):1185-1192. doi: 10.1016/j.jvir.2019.03.018. Epub 2019 Jun 27.

引用本文的文献

Design and optimization of imageable microspheres for locoregional cancer therapy.用于局部区域癌症治疗的可成像微球的设计与优化。

Sci Rep. 2025 Jul 28;15(1):27487. doi: 10.1038/s41598-025-12182-5.

Tumor Dose as an Oncologic Predictor of Outcome in Patients with HCC Treated with Resin Y90 Microspheres.肿瘤剂量作为接受树脂钇90微球治疗的肝癌患者预后的肿瘤学预测指标。

Cardiovasc Intervent Radiol. 2025 Jul 10. doi: 10.1007/s00270-025-04113-8.

Radioembolization of hepatocellular carcinoma with Y glass microspheres: an earlier administration day unexpectedly improves tumour control probability.用钇玻璃微球进行肝细胞癌的放射性栓塞：意外提前给药日可提高肿瘤控制概率。

Eur J Nucl Med Mol Imaging. 2025 May 21. doi: 10.1007/s00259-025-07295-y.

Measure of Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison Tc-MAA SPECT/CT dosimetry.使用PET/CT测量TARE后Y玻璃微球残留情况及其与Tc-MAA SPECT/CT剂量测定法相比对肿瘤吸收剂量的潜在影响。

EJNMMI Rep. 2024 Aug 26;8(1):26. doi: 10.1186/s41824-024-00214-8.

Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study.树脂基 90Y 肿瘤剂量预测不可切除肝细胞癌患者反应持续时间和生存的前瞻性单臂研究。

Clin Nucl Med. 2024 Sep 1;49(9):799-805. doi: 10.1097/RLU.0000000000005198. Epub 2024 May 21.

Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.神经内分泌肝脏转移的肝脏导向局部治疗：最新进展与管理。

Curr Oncol. 2024 Apr 5;31(4):2076-2091. doi: 10.3390/curroncol31040154.

Transarterial Radioembolization for Management of Hepatocellular Carcinoma.经动脉放射栓塞治疗肝细胞癌。

Oncologist. 2024 Feb 2;29(2):117-122. doi: 10.1093/oncolo/oyad327.

The Importance of Uncertainty Analysis and Traceable Measurements in Routine Quantitative Y-PET Molecular Radiotherapy: A Multicenter Experience.不确定性分析和可溯源测量在常规定量Y-PET分子放射治疗中的重要性：一项多中心经验

Pharmaceuticals (Basel). 2023 Aug 11;16(8):1142. doi: 10.3390/ph16081142.

Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C).Y90 放射性栓塞治疗巴塞罗那临床肝癌分期 C（BCLC-C）肝癌患者的总生存和毒性。

BMC Gastroenterol. 2022 Nov 17;22(1):467. doi: 10.1186/s12876-022-02528-y.

Spatial density and tumor dosimetry are important in radiation segmentectomy with Y glass microspheres.在使用钇玻璃微球进行放射性节段切除术时，空间密度和肿瘤剂量测定很重要。

Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3607-3609. doi: 10.1007/s00259-022-05819-4.

本文引用的文献

The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.90Y 玻璃微球每格雷的低肝毒性与其在动脉树中的运输有关，这有利于非均匀捕获，正如治疗后 PET 成像所观察到的那样。

J Nucl Med. 2014 Jan;55(1):135-40. doi: 10.2967/jnumed.113.126839. Epub 2013 Dec 2.

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):486-93. doi: 10.1007/s00259-013-2575-8. Epub 2013 Oct 10.

Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review.放射性栓塞治疗结直肠癌肝转移挽救治疗患者：系统评价。

J Nucl Med. 2013 Nov;54(11):1890-5. doi: 10.2967/jnumed.113.119545. Epub 2013 Sep 26.

Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.用钇-90 进行放射性栓塞治疗合并门静脉癌栓的肝细胞癌：新出现的治疗方法。

Oncology. 2013;84(5):311-8. doi: 10.1159/000348325. Epub 2013 Apr 18.

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.载钇 90 玻璃微球增强选择性内放射治疗（B-SIRT）用于肝癌患者：一种新的个体化有前途的概念。

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1057-68. doi: 10.1007/s00259-013-2395-x. Epub 2013 Apr 24.

Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.钇90放射性栓塞治疗肝细胞癌：生物学启示、当前挑战及临床前景

Hepatology. 2013 Dec;58(6):2188-97. doi: 10.1002/hep.26382. Epub 2013 Oct 4.

A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.一种使用90Y玻璃微球进行肝癌放射性栓塞治疗的剂量学治疗计划策略。

Q J Nucl Med Mol Imaging. 2012 Dec;56(6):503-8.

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study.钇 90 放射性栓塞治疗中晚期肝细胞癌：一项 2 期研究。

Hepatology. 2013 May;57(5):1826-37. doi: 10.1002/hep.26014. Epub 2013 Mar 22.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.索拉非尼治疗晚期肝细胞癌患者的疗效和安全性：III 期临床试验的亚组分析。

J Hepatol. 2012 Oct;57(4):821-9. doi: 10.1016/j.jhep.2012.06.014. Epub 2012 Jun 19.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理

J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验